• Become a Partner
  • Get EpiSign™
  • About Us
    • Mission & Vision
    • History
    • Partners
    • Equity, Diversity and Inclusion
  • Our Team
    • Leadership Team
    • Our Board of Directors
    • External Scientific Advisory Board
  • Technology & Products
  • Research & News
  • Contact Us
  • About Us
    • Mission & Vision
    • History
    • Partners
    • Equity, Diversity and Inclusion
  • Our Team
    • Leadership Team
    • Our Board of Directors
    • External Scientific Advisory Board
  • Technology & Products
  • Research & News
  • Contact Us

Breaking News

New joint initiative with Ontario Brain Institute to advance diagnosis of rare genetic disorders

Read more

Pioneering Epigenetic Research

Explore our breakthroughs in epigenetics research. Our publications in top scientific journals highlight our role in advancing diagnostic approaches for rare diseases. With a focus on real-world applications, we’re defining the future of genomic medicine.

Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic disorders

March 25, 2025

Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases

van Karnebeek C, O'Donnell-Luria A, Baynam G, Baudot A, Groza T, Jans J, Lassmann T, Letinturier M, Montgomery B, Robinson P, Sansen S, Mehrian-Shai R, Steward C, Kosaki K, Duran P, Sadikovic B.

Orphanet Journal of Rare Diseases

Article number: 357 (2024)

Publication

World first discoveries allow researchers to accurately diagnose prenatal exposure syndromes and birth disorders

July 31, 2024
News

2022 KAT6A KAT6B Conference

Video

2023 SERN/SERGG Annual Meeting

Video
Depiction of person with many different tissue types highlighted

Rounds at McMaster (Jan 2023)

Video
  • 1
100 Collip Circle
Suite 120, Office 1
London ON N6G 4X8
1-833-EPISIGN
info@episign.com

© 2025 Episign. | All Rights Reserved

· Privacy Policy · Security and Data Protection | Designed & Developed by RhinoActive